glp-1 diarrhea treatment Full article: Managing the gastrointestinal side effects of receptor agonists in obesity: recommendations for clinical practice GLP-1RA Essentials in Gastroenterology: Side

Glucagon-like peptide-1 mobilizes intracellular Ca2+ and stimulates mitochondrial ATP synthesis in pancreatic MIN6 beta-cells

The United States already has one of the most permissive pharmaceutical advertising systems in the world

Fernandes BS, Molendijk ML, Kohler CA, Soares JC, Leite CM, Machado-Vieira R, et al

April 21, 2026: Parties Submit Status Report Ahead of Hearing in MDL Involving Lawsuits Over Zepbound, Other GLP-1s Dozens of people who took GLP-1 drugs, like Zepbound, have filed lawsuits, claiming they developed severe side effects that they were not warned about

In the ATTAIN-1 Phase 3 trial, the most frequently reported adverse events with orforglipron 36 mg versus placebo were nausea (33.7% vs 10.4%), constipation (25.4% vs 9.3%), diarrhea (23.1% vs 9.6%), and vomiting (24.0% vs 4.0%)

And stop the drug, and the weight often comes back